• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREP2 CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREP2 CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/14/2018
Event Type  malfunction  
Manufacturer Narrative
Na.
 
Event Description
The customer stated that they received erroneous results for four patient samples tested for crep2 creatinine plus ver.2 on a cobas 6000 c (501) module.The customer stated that the analyzer switched from using their current crep2 reagent pack to using a standby pack.The affected samples appeared to be tested using the standby pack and that there were no issues with sample results measured from the current pack.The third patient sample also had an erroneous result for ise indirect (b)(6) for gen.2.This medwatch will apply only to the crep2 assay.Please refer to the medwatch with patient identifier (b)(6) for information related to (b)(6).All erroneous initial results were reported outside of the laboratory.The repeat results were believed to be correct.The first patient sample initially resulted with a crep2 value of 3.29 mg/dl.When repeated on (b)(6) 2018, the sample resulted with a crep2 value of 0.74 mg/dl.The second patient sample, from a (b)(6) year old female patient, initially resulted with a crep2 value of 5.90 mg/dl.When repeated on (b)(6) 2018, the sample resulted with a crep2 value of 0.91 mg/dl.The third patient sample, from a (b)(6) year old female patient, initially resulted with a crep2 value of 5.38 mg/dl.When repeated on (b)(6) 2018, the sample resulted with a crep2 value of 1.04 mg/dl.This sample initially resulted with a (b)(6) value of 3.73 mmol/l, which repeated as 4.3 mmol/l on (b)(6) 2018.The fourth patient sample, from a (b)(6) year old female patient, initially resulted with a crep2 value of 5.37 mg/dl.When repeated on (b)(6) 2018, the sample resulted with a crep2 value of 0.87 mg/dl.The second patient was transferred to the intensive care unit based on the erroneous result, but was later transferred elsewhere once the correct result was received.No adverse events were alleged to have occurred with all patients.The customer replaced the crep2 reagent pack, then ran calibration and controls.Controls were within specification.The field service engineer determined that the analyzer was functioning properly.Precision testing showed good results.He stated that it appears that the reagent pack that was on board the system caused an issue since it was at the end of the its total pack volume.The issue with the erroneous crep2 values was resolved by the customer and engineer actions.Calibration and controls tested prior to the event were ok.For the issue with the erroneous crep2 values, the investigation could not identify a product problem.The cause of this event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREP2 CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7854983
MDR Text Key119661469
Report Number1823260-2018-03021
Device Sequence Number1
Product Code JFY
UDI-Device Identifier04015630919215
UDI-Public4015630919215
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/07/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Catalogue Number03263991190
Device Lot Number30284701
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/15/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age91 YR
-
-